INSIGHTS ON CLINICAL TRIAL DESIGN

  • Overcoming Challenges In Obesity Trials
    2/12/2026

    Obesity trials face high dropout rates due to long durations and complex requirements. Overcome these hurdles with personalized engagement, expert lifestyle support, and proactive patient care.

  • Powering Complex Personalized Medicine Oncology Trial
    2/25/2026

    Managing custom therapies requires a synchronized supply chain. Learn how to bridge the gap between manufacturing and clinical workflows to ensure seamless patient care in complex oncology trials.

  • Pay-By-Procedure Or Pay-By-Visit: Which Model Fits Your Trial?
    5/28/2026

    Site payment models shape trial cost and execution. Compare visit‑based simplicity vs procedure‑level precision to see when flexibility and savings beat complexity — or when predictability wins.

     

  • Enhancing Clinical Trial Flexibility
    9/1/2025

    Once seen primarily as staffing extensions, FSPs have evolved into strategic partners that deliver flexibility, scalability, and tailored expertise.

  • Reducing Inventory Errors In Clinical Trials
    5/8/2026

    Can a digital double-check save your trial from data errors? How does verifying shipments at receipt slash inventory mistakes? Learn to protect protocol integrity and patient safety.

CLINICAL TRIAL DESIGN SOLUTIONS

  • Ensure accurate, compliant, and impactful documentation with Altasciences' experienced medical writers and regulatory experts.

  • Built From The Ground Up

    Block Clinical understood from the beginning that intuitive technology that integrates openly with other systems and suppliers is the key to a streamlined, affordable solution.

  • Explore a platform that benefits the entire global clinical trial ecosystem by reducing complexity and operational costs while maintaining the highest standards of data security and subject privacy.

  • Integrate sensors into your study to evaluate digital endpoints with a comprehensive solution that accelerates drug development, reduces patient sample sizes, cuts costs, and improves patient insights.

  • CNS drug development faces unique hurdles — from high placebo response to complex protocols and recruitment challenges. Discover strategies to streamline trials, optimize planning, and accelerate delivery of innovative therapies for patients with critical unmet needs.